Trial Profile
Study to evaluate the effect of multiple doses of Upadacitinib on the pharmacokinetics of Levonorgestrel and Ethinylestradiol in healthy subjects
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 13 Dec 2017
Price :
$35
*
At a glance
- Drugs Upadacitinib (Primary) ; Ethinylestradiol/levonorgestrel
- Indications Rheumatoid arthritis
- Focus Pharmacokinetics
- 13 Dec 2017 New trial record
- 08 Nov 2017 Results presented at the 81st American College of Rheumatology and the 52nd Association of Rheumatology Health Professionals Annual Scientific Meeting